Shih‐Jen Liu

机构：Kaohsiung Medical University, National Health Research Institutes, China Medical University, National Institute of Infectious Diseases, China Medical University · ORCID：0000-0002-8736-1452

发表论文 132 篇 · 总被引 3494 次 · h-index 32

代表论文

• Advances in nucleic acid-based cancer vaccines (2025 · Journal of Biomedical Science · 被引 40)
• Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapy (2024 · Nature Cancer · 被引 35)
• Lipid nanoparticle-encapsulated DNA vaccine robustly induce superior immune responses to the mRNA vaccine in Syrian hamsters (2023 · Molecular Therapy — Methods & Clinical Development · 被引 32)
• TLR9 and STING agonists cooperatively boost the immune response to SARS-CoV-2 RBD vaccine through an increased germinal center B cell response and reshaped T helper responses (2023 · International Journal of Biological Sciences · 被引 20)
• Humoral and cellular immunity in three different types of COVID-19 vaccines against SARS-CoV-2 variants in a real-world data analysis (2023 · Journal of Microbiology Immunology and Infection · 被引 14)
• A TLR9 agonist synergistically enhances protective immunity induced by an Alum-adjuvanted H7N9 inactivated whole-virion vaccine (2023 · Emerging Microbes & Infections · 被引 13)